NIDEK Hyperopia Clinical Study Update & Future FDA Studies
-Fremont, CA USA, May 4th, 2004-
NIDEK, Inc. announced today that it has completed and submitted 3-month clinical data for its new hyperopia study to the FDA. This marks an important milestone in the study process, as additional treatment eyes will be initiated in the study protocol effective [...]
30. January 2008
Comments Off
The NIDEK EC-5000 Excimer Laser System (including EC-5000CX/CXII) has been approved for use in the United States to perform photorefractive keratectomy (PRK) for the reduction or elimination of myopia in the low, moderate or high ranges (-0.75 to -13.00 D), spherical equivalent at the spectacle plane, uncomplicated by refractive astigmatism (i.e. equal or less than [...]
Continue reading...
30. January 2008
Comments Off